Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCKBR | P32239 | 6/20 | 0.50 |
| ▸ | OPRD1 | P41143 | 5/20 | 0.50 |
| ▸ | CCKAR | P32238 | 4/20 | 0.50 |
| ▸ | QRFPR | Q96P65 | 3/20 | 0.49 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.49 |
| ▸ | MMP2 | P08253 | 9/20 | 0.48 |
| ▸ | MMP1 | P03956 | 4/20 | 0.48 |
| ▸ | MMP3 | P08254 | 4/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29311715 | 1.00 | CCKBR (0.50) | CCKBROPRD1CCKARQRFPRPTPN1 | |
| SCHEMBL27273355 | 0.93 | QRFPR (0.48) | QRFPR | |
| SCHEMBL27268466 | 0.92 | KEAP1 (0.51) | CCKBROPRD1CCKARQRFPR | |
| SCHEMBL29311919 | 0.90 | KEAP1 (0.56) | CCKBROPRD1CCKAR | |
| SCHEMBL29313289 | 0.89 | QRFPR (0.47) | CCKBROPRD1CCKARQRFPR | |
| SCHEMBL27272114 | 0.89 | QRFPR (0.47) | CCKBROPRD1CCKARQRFPR | |
| SCHEMBL29311906 | 0.86 | CTSB (0.60) | OPRD1 | |
| SCHEMBL27268400 | 0.86 | CTSB (0.60) | OPRD1 | |
| SCHEMBL29313281 | 0.84 | QRFPR (0.49) | QRFPR | |
| SCHEMBL29313314 | 0.84 | QRFPR (0.49) | QRFPR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240228671-A1 | POLYPEPTIDYL LINKERS | Quantum-Si Incorporated (US) | 2024-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240228671-A1 | POLYPEPTIDYL LINKERS | VIP, DNPEP, PREP | CCKBR 332/4885OPRD1 3695/4885CCKAR 613/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.